Resources
The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.
Filter by:
Topic
Topic
- Alternative Payment Models
- Biopharmaceutical Innovation
- Elements of Value
- Evidence for Decision Making
- (-) Good Practices for Evidence
- Health Care Quality Measures
- (-) Health Spending
- Patient Centered Formulary & Benefit Design
- Policy & Regulatory Barriers
- Real-World Data
- Real-World Evidence
- Understanding Health Spending
- Utilization Management & Step Therapy
- (-) Value-Based Insurance Design
- Value Assessment
- Value Assessment Frameworks
- Value Assessment Methods
Resource Type
Display Only
Showing 8 Results
NPC Submits Comments to CMS on Medicaid Drug Rebate Program
In this comment letter, NPC weighs in on CMS' proposed rule changes to the Medicaid Drug Rebate Program (MDRP).
NPC Comments on the Medicare Program's Hospital Inpatient Prospective Payment Systems
NPC's comments to CMS focus on recent proposals related to the transition to National Drug Codes for New Technology Add-on Payments and recommendations regarding payment mechanisms to improve access…
Digging Deeper Into Health Spending | November 2021
In this e-newsletter, NPC will dig deeper into health care spending and highlight the importance of relying on good research to create good policy.
NPC Comments on Most Favored Nation (MFN) Model [CMS-5528-IFC]
NPC explains how using payment models based on pricing in other countries could have a negative impact on patient outcomes, access to treatments and future innovation.
NPC Comments on PCORI's Proposed Principles for the Consideration of the Full Range of Outcomes Data
NPC offered public feedback to PCORI on its new mandate to consider the full range of patient-centered outcomes in its research.